Comparar métodos

	Análise Proteômica Bayesiana	Análise Proteômica
Área	Bioinformática	Bioinformática
Família	Process / pipeline	Process / pipeline
Ano de origem	2000s (major developments 2003–2010)	1994–2003 (term coined 1994; shotgun proteomics established early 2000s)
Autor original	Multiple contributors; foundational statistical frameworks by Nesvizhskii, Kall, Choi, and colleagues	Marc Wilkins, Matthias Mann, Ruedi Aebersold (proteome/mass spectrometry foundations)
Tipo	Probabilistic inference pipeline	Quantitative omics pipeline
Fonte seminal	Kall, L., Canterbury, J. D., Weston, J., Noble, W. S., & MacCoss, M. J. (2008). Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nature Methods, 5(11), 923–925.	Wilkins, M. R., Sanchez, J.-C., Gooley, A. A., Appel, R. D., Humphery-Smith, I., Hochstrasser, D. F., & Williams, K. L. (1996). Progress with proteome projects: Why all proteins expressed by a genome should be identified and how to do it. Biotechnology and Genetic Engineering Reviews, 13(1), 19–50.
Outros nomes	Bayesian protein quantification, Bayesian peptide inference, probabilistic proteomics, Bayesian mass spectrometry analysis	proteomics, mass spectrometry-based proteomics, shotgun proteomics, quantitative proteomics
Relacionados	6	6
Resumo	Bayesian proteomics analysis applies probabilistic models to mass spectrometry data to identify peptides, infer protein presence, and quantify differential protein abundance across conditions. By encoding prior knowledge and propagating uncertainty through each step of the pipeline, Bayesian approaches produce calibrated posterior probabilities of identification and quantification rather than simple point estimates, enabling more principled control of false discovery rates and more honest reporting of uncertainty than purely frequentist alternatives.	Proteomics analysis is a systematic pipeline for identifying and quantifying proteins in biological samples using mass spectrometry. Starting from raw spectral data, the workflow searches protein sequence databases, estimates abundance across conditions, applies statistical tests for differential expression, and maps findings onto biological pathways. It complements transcriptomics by capturing post-translational regulation and actual protein abundance, and is central to biomarker discovery, drug-target identification, and systems biology.